Skip to content
Search

Latest Stories

Women’s health startup pulls in £4.2m in seed funding

A women's health startup has secured multi-million pound investment to "revolutionise" reproductive health.

Hertility Health has raised £4.2m in seed funding in a round led by UK seed investor LocalGlobe, Venrex and some key angel investors, including former Bupa boss Evelyn Bourke, and CEO of Nested and GoCardless Matt Robinson.


The company was founded in 2020 by scientists Dr Helen O’Neill, Dr Natalie Getreu and Deirdre O’Neill -- while on their maternity leave -- during the pandemic. According to them, Hertility Health addresses one of the biggest market segments in which there has been little advancement for many years.

It specialises in reducing diagnosis times for women’s health issues such as endometriosis and polycyctic ovarian syndrome (PCOS).

The investment will help Hertility Health expand its current product offering of fertility and hormone testing, menopause, miscarriage, postnatal care, PCOS and endometriosis testing, as well as aid the expansion of its current clinical trials which aim to reduce diagnosis time for conditions and firm up the company's position as a scientific and clinical educational health hub for women.

CEO O’Neill said: “Some of the women spend over ten years on their contraception, never being fully aware that there might be something wrong. On an average, one in five Hertility Health users were found to have a previously undiagnosed reproductive condition which has been revealed as a result of testing with Hertility Health.”

Julia Hawkins from LocalGlobe said: “Together, we’re excited to help Hertility Health become the home for women’s health, building on its  success to date and meeting the clear consumer demand for an accessible, affordable, high-quality solution to reproductive health concerns and curiosity.”

Mark Esiri of Venrex Investment Management, said: “Venrex tries to find creative entrepreneurs who often have ‘differences of opinion’ with the status quo. This has been a common thread at companies we have been lucky enough to back, including Revolut, Charlotte Tilbury, Mumsnet, NotOnTheHighStreet and Maven Clinic. We are very fortunate to be working with the Hertility Health team who are bringing world class technical expertise, a data-driven approach and relentless energy to address deeply important health issues. We believe that the founders will use their expertise to positively change the world.”

So far, the start up has helped over 2,000 women understand their reproductive health and infertility risks, offering fertility counselling to those in need.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less